Xenobiotica: Editorial

Xenobiotica

Volumn 37, Issue 10-11, 2007, Pages 1013-1014

  Gibson, G Gordon ^a   Rostami Hodjegan, Amin ^b  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

XENOBIOTIC AGENT;

DRUG ABSORPTION; DRUG EXCRETION; DRUG METABOLISM; EDITORIAL; FOOD AND DRUG ADMINISTRATION; MEDICAL RESEARCH; RECEPTOR BINDING; SCIENTIFIC LITERATURE; SIMULATION; BIOLOGICAL MODEL; DRUG DESIGN; HUMAN; IN VITRO STUDY; METABOLISM;

DRUG DESIGN; HUMANS; MODELS, BIOLOGICAL; XENOBIOTICS;

EID: 35649016144     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.1080/00498250701649873     Document Type: Editorial

References (3)

1. Buckman S, Huang S-M, Murphy S. 2007. Medical product development and regulatory science for the 21st century: the critical path vision and its impact on health care. Clinical Pharmacology and Therapy 81:141-144.
2. Rostami-Hodjegan A, Tucker GT. 2004. 'In silico' simulations to assess the 'in vivo' consequences of 'in vitro' metabolic drug-drug interactions. Drug Discovery Today Technology 9:441-448.
3. Rostami-Hodjegan A, Tucker GT. 2007. Simulation and prediction of in vivo drug metabolism in human populations from in vitro data. Nature Reviews in Drug Discovery 6:140-148.